CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Andrea Quattrone

OPENALEX: A5004029818↗ORCID: 0000-0003-2071-2083↗

Affiliations

Organizations

South London and Maudsley NHS Foundation Trustauthorship · GB Universidade do Portoauthorship · PT University of Messinaauthorship · IT

Public evidence

4 connected articles

Are reasons for first using cannabis associated with subsequent cannabis consumption (standard THC units) and psychopathology?2025 · Europe PMC A proof-of-concept analysis of data from the first NHS clinic for young adults with comorbid cannabis use and psychotic disorders.2024 · Europe PMC Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.2021 · PubMed Central Open Access The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.2021 · PubMed Central Open Access

Registered research

Connected studies

Testing the Efficacy of the Cannabis Clinic for Patients With Psychosis (CCP) Intervention for Cannabis Use Reduction/Cessation in Patients With First Episode Psychosisnct07245212

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Andrea Quattrone - Medical Cannabis Research Engine